|
|
|
A BILL TO BE ENTITLED
|
|
AN ACT
|
|
relating to a medical cannabis research program. |
|
BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS: |
|
SECTION 1. Section 481.062(a), Health and Safety Code, is |
|
amended to read as follows: |
|
(a) The following persons may possess a controlled |
|
substance under this chapter without registering with the Federal |
|
Drug Enforcement Administration: |
|
(1) an agent or employee of a manufacturer, |
|
distributor, analyzer, or dispenser of the controlled substance who |
|
is registered with the Federal Drug Enforcement Administration and |
|
acting in the usual course of business or employment; |
|
(2) a common or contract carrier, a warehouseman, or |
|
an employee of a carrier or warehouseman whose possession of the |
|
controlled substance is in the usual course of business or |
|
employment; |
|
(3) an ultimate user or a person in possession of the |
|
controlled substance under a lawful order of a practitioner or in |
|
lawful possession of the controlled substance if it is listed in |
|
Schedule V; |
|
(4) an officer or employee of this state, another |
|
state, a political subdivision of this state or another state, or |
|
the United States who is lawfully engaged in the enforcement of a |
|
law relating to a controlled substance or drug or to a customs law |
|
and authorized to possess the controlled substance in the discharge |
|
of the person's official duties; |
|
(5) if the substance is tetrahydrocannabinol or one of |
|
its derivatives: |
|
(A) a Department of State Health Services |
|
official, a medical school researcher, or a research program |
|
participant possessing the substance as authorized under |
|
Subchapter G or G-1, including all persons permitted or otherwise |
|
authorized to possess cannabis under Subchapter G-1; or |
|
(B) a practitioner or an ultimate user possessing |
|
the substance as a participant in a federally approved therapeutic |
|
research program that the commissioner has reviewed and found, in |
|
writing, to contain a medically responsible research protocol; or |
|
(6) a dispensing organization licensed under Chapter |
|
487 that possesses low-THC cannabis. |
|
SECTION 2. Chapter 481, Health and Safety Code, is amended |
|
by adding Subchapter G-1 to read as follows: |
|
SUBCHAPTER G-1. MEDICAL CANNABIS RESEARCH PROGRAM |
|
Sec. 481.251. DEFINITION. In this subchapter, "commission" |
|
means the Health and Human Services Commission. |
|
Sec. 481.252. MEDICAL CANNABIS RESEARCH PROGRAM. (a) Not |
|
later than January 31, 2022, the executive commissioner by rule |
|
shall establish a medical cannabis research program to be conducted |
|
by health-related institutions of higher education in this state. |
|
(b) In adopting rules under this section, the executive |
|
commissioner may provide: |
|
(1) procedures for a health-related institution of |
|
higher education in this state to apply to the commission for a |
|
permit to conduct medical cannabis research under the program |
|
established by this subchapter; and |
|
(2) criteria for granting a permit to a health-related |
|
institution of higher education to conduct medical cannabis |
|
research. |
|
Sec. 481.253. INSTITUTIONAL REVIEW BOARD. (a) Before |
|
applying for a permit under this subchapter, a health-related |
|
institution of higher education shall establish an institutional |
|
review board to review or approve the initiation of and conduct |
|
periodic review of research programs to ensure the legal protection |
|
of the rights and welfare of human research subjects. |
|
(b) The institution may designate an existing board, |
|
committee, or other group as the institutional review board |
|
required under this section. |
|
Sec. 481.254. COMPASSIONATE-USE RESEARCH. (a) A |
|
health-related institution of higher education may apply for a |
|
permit to research: |
|
(1) the efficacy of medical cannabis product |
|
formulations and product forms; |
|
(2) medical conditions that might benefit from |
|
treatment with medical cannabis and are approved by the |
|
health-related institution's institutional review board, including |
|
those not listed in Section 169.003, Occupations Code; and |
|
(3) any other research matter approved by the |
|
institution's institutional review board. |
|
(b) In applying for a permit, the health-related |
|
institution of higher education shall disclose any private sector |
|
organization contractors under Section 481.255 and shall disclose |
|
additional contractors as additional contractors are formed. |
|
Sec. 481.255. CONTRACTORS. (a) A health-related |
|
institution of higher education granted a permit under this |
|
subchapter shall be authorized to contract with one or more private |
|
sector organizations to fulfill the terms of the permit, including |
|
contracting for the production and distribution of medical |
|
cannabis. |
|
(b) A private sector organization is eligible to contract |
|
with a health-related institution of higher education under this |
|
subchapter if the organization: |
|
(1) meets all requirements for a dispensing |
|
organization under Chapter 487, except that the participant is not |
|
required to pay a licensing or application fee; |
|
(2) demonstrates capability to provide funding to |
|
support medical cannabis research activities at a health-related |
|
institution of higher education; |
|
(3) demonstrates capability to establish and operate a |
|
production and distribution system sufficient to support research |
|
program needs; and |
|
(4) is not a dispensing organization licensed under |
|
Chapter 487, owned or controlled by any direct or indirect owner of |
|
a licensed dispensing organization, or otherwise affiliated with a |
|
licensed dispensing organization. |
|
(c) The commission shall approve contractors between |
|
health-related institutions of higher education and private sector |
|
organizations authorized under this subchapter. |
|
Sec. 481.256. PATIENT TREATMENT. (a) Patient treatment |
|
provided as part of an approved research program under this |
|
subchapter may be administered only by a medical practitioner |
|
meeting standards approved by the institution's institutional |
|
review board. |
|
(b) A patient participating in a research program under this |
|
subchapter must be a permanent resident of this state. |
|
Sec. 481.257. INFORMED CONSENT. (a) Before receiving |
|
treatment under an approved research program, each patient must |
|
sign a written informed consent form. |
|
(b) If a patient is a minor or lacks the mental capacity to |
|
provide informed consent, a parent, guardian, or conservator may |
|
provide informed consent on the patient's behalf. |
|
(c) The executive commissioner shall adopt a form to be used |
|
for the informed consent required by this section. |
|
Sec. 481.258. LICENSURE AS DISPENSING ORGANIZATION. A |
|
private sector organization contracting with a health-related |
|
institution of higher education under this subchapter shall be |
|
eligible for licensure as a dispensing organization under Chapter |
|
487, or any other law that authorizes cultivating, processing, and |
|
dispensing cannabis, on or after the second anniversary of the date |
|
the organization entered into a contract with a health-related |
|
institution of higher education related to a research program |
|
authorized under this subchapter, provided that the organization's |
|
operations comply with applicable state law. |
|
SECTION 3. This Act takes effect September 1, 2021. |